Skip to main content
SpringerLink
Log in

Recurrent upper GI bleeding with celecoxib or naproxen

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. CONCERN; NCT00153660

References

  1. Chan FKL, et al. Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial. Lancet : 11 Apr 2017. Available from: URL: http://dx.doi.org/10.1016/S0140-6736(17)30981-9.

  2. McGettigan P, et al. NSAIDs for high-risk patients: none, celecoxib, or naproxen? Lancet : 11 Apr 2017. Available from: URL: http://dx.doi.org/10.1016/S0140-6736(17)30980-7.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Recurrent upper GI bleeding with celecoxib or naproxen. Reactions Weekly 1648, 10 (2017). https://doi.org/10.1007/s40278-017-28989-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-28989-5

Search

Navigation